CompletedNCT00126282
D-cycloserine added to exposure therapy for obsessive-compulsive symptoms
About this title
A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder
Read the official source — NCT00126282Medication studyAges 18+United StatesOCD
Understand this study
Who was this study for?
This study was for people with OCD. Listed age limits: from 18 years. Other eligibility criteria applied.
- Listed locations
- Hartford and 1 more locationSee all locations and recruitment
Study information
Study start dateDecember 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 50
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT00126282
- Official title
Show the full official title
A Randomized, Double-blind, Placebo-controlled Medication Trial With D-Cycloserine for Individuals With Obsessive-compulsive Disorder Currently Receiving Behavior Therapy
Get this study by email
Recruitment & locations
CompletedHartford · Boston
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including D-Cycloserine.
Who was this study for?
This study was for people with OCD. Listed age limits: from 18 years. Other eligibility criteria applied.
